Early research (Phase 1)Study completedNCT02045472What this trial is testingVIS410 to Assess Safety and PharmacokineticsWho this might be right forInfluenza Visterra, Inc. 41
Early research (Phase 1)Study completedNCT01840501What this trial is testingEvaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-42721458 in Healthy Male ParticipantsWho this might be right forHealthy Janssen Research & Development, LLC 108
Testing effectiveness (Phase 2)Looking for participantsNCT07085507What this trial is testingSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VT7208 in Healthy Participants and MS PatientsWho this might be right forMultiple Sclerosis Vidya Therapeutics Inc 100
Early research (Phase 1)Study completedNCT02629744What this trial is testingEvaluate Pain, Tolerability, Safety, and Usability of a Single Self-administered Etrolizumab by Auto-injector in Healthy ParticipantsWho this might be right forHealthy Volunteer Genentech, Inc. 27
Early research (Phase 1)Study completedNCT05192395What this trial is testingA Crossover Study of DWJ1525 to Evaluate the Safety and Pharmacokinetic Properties in Healthy VolunteersWho this might be right forHealthy Daewoong Pharmaceutical Co. LTD. 37
Early research (Phase 1)Study completedNCT01814839What this trial is testingA Phase 1, Single- and Multi-Dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered ALN-TTRSC (Revusiran) in Healthy VolunteersWho this might be right forTTR-mediated Amyloidosis Alnylam Pharmaceuticals 85
Early research (Phase 1)Active Not RecruitingNCT06783881What this trial is testingSingle-ascending Dose Study of Kylo-12 in Healthy SubjectsWho this might be right forHypertriglyceridemia Kylonova (Xiamen) Biopharma co., LTD. 50
Early research (Phase 1)Study completedNCT02339207What this trial is testingFirst in Human Study of AL-335; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1Who this might be right forChronic Hepatitis C Alios Biopharma Inc. 112
Early research (Phase 1)Study completedNCT02737371What this trial is testingMultiple Ascending Oral Dose Study of F901318 in Healthy SubjectsWho this might be right forInvasive Aspergillosis F2G Ltd 40
Early research (Phase 1)Study completedNCT06821464What this trial is testingA Trial of HRS-9813 in Healthy SubjectsWho this might be right forIdiopathic Pulmonary Fibrosis/Progressive Pulmonary Fibrosis Guangdong Hengrui Pharmaceutical Co., Ltd 45
Early research (Phase 1)Study completedNCT03250598What this trial is testingStudy to Evaluate the Pharmacokinetics, Safety, and QTc Effect of AG-348 in Healthy Subjects of Japanese Origin and Non-Asian OriginWho this might be right forHealthyJapaneseNon-Asian Agios Pharmaceuticals, Inc. 60
Early research (Phase 1)Study completedNCT04488900What this trial is testingEvaluation of the Safety and Tolerability of CKD-508 in Healthy SubjectsWho this might be right forHealthy Subjects Chong Kun Dang Pharmaceutical 88
Early research (Phase 1)Study completedNCT02658864What this trial is testingPharmacokinetic Properties and Effect of Food on Pharmacokinetic Properties of the Oral Lafutidine TabletsWho this might be right forChronic Gastritis Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 12
Early research (Phase 1)Study completedNCT02454699What this trial is testingSafety and PK of MBX-400 (Cyclopropavir) in Normal VolunteersWho this might be right forCytomegalovirus Infection National Institute of Allergy and Infectious Diseases (NIAID) 24
Early research (Phase 1)Study completedNCT00938301What this trial is testingA First In Human Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of PF-04455242 In Single Rising Doses In Healthy Adult VolunteersWho this might be right forBipolar Depression Pfizer 18
Early research (Phase 1)Ended earlyNCT05064436What this trial is testingEvaluate the Safety, Tolerability, Kinetics, Biodistribution and Repeatability of 11C-BMS-986196 After Intravenous (IV) Administration in Healthy Participants and After Repeat IV Administration in Participants With Multiple SclerosisWho this might be right forMultiple Sclerosis (MS) Bristol-Myers Squibb 10
Early research (Phase 1)Study completedNCT04493671What this trial is testingEvaluate Safety, Tolerability, PK of TBAJ-876 in Healthy AdultsWho this might be right forPulmonary DiseaseTuberculosis, PulmonaryTuberculosis+4 more Global Alliance for TB Drug Development 137
Early research (Phase 1)Study completedNCT01920399What this trial is testingA Phase I Study to Assess the Safety, Tolerability and PK of Ceftazidime-Avibactam in Healthy Chinese SubjectsWho this might be right forHealthy Volunteers Pfizer 42
Early research (Phase 1)Study completedNCT01947738What this trial is testingSafety Study of VBY-891 in Healthy Volunteers After Single or Multiple (7 Days) of Oral Dosing (VBY891P1)Who this might be right forHealthy Virobay Inc. 89
Early research (Phase 1)UnknownNCT06533878What this trial is testingEvaluate Tolerability and Safety of HY209 in Healthy VolunteersWho this might be right forDementia Kukjeon Pharmaceutical Co.,Ltd. 59